The 20 Best Pseudomyxoma Peritonei Doctors near San Francisco, CA

John Chan is an Oncologist and an Obstetrics and Gynecologist in San Francisco, California. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Adult Soft Tissue Sarcoma, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Oophorectomy, and Bladder Reconstruction. Dr. Chan is currently accepting new patients.

Stephanie Jeske is an Oncologist in San Francisco, California. Dr. Jeske is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Jeske is currently accepting new patients.

Caring, compassionate, and patient centric care. Dr. Quock is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

Dr. Mohamed Adam is a cancer surgeon who cares for patients with gastrointestinal tumors. Having particular expertise in using minimally invasive robotic techniques, he performs robotic pancreaticoduodenectomy (also known as the Whipple procedure) to treat certain cancers of the pancreas and bile ducts. He is also experienced in treating tumors that have spread to the liver and peritoneal cavity (the space between membranes lining the abdomen, pelvis and abdominal organs), such as by implanting a hepatic artery infusion pump (a device that delivers chemotherapy directly to the liver) for patients with inoperable liver disease, and through a protocol that combines cytoreductive surgery (removing visibly diseased tissues in the abdominal cavity) with hyperthermic intraperitoneal chemotherapy (pumping strong doses of heated anticancer drugs through the abdomen). Adam's research focuses on using artificial intelligence systems, including machine learning algorithms, to optimize cancer treatments. He has authored more than 100 publications. Adam earned his medical degree at Omdurman Islamic University in Sudan. He completed a residency in general surgery at Duke University Medical Center, where he also completed a research fellowship in advanced statistical modeling. He completed a fellowship in complex surgical oncology at the University of Pittsburgh Medical Center. Adam is a member of several professional societies and the recipient of many academic honors at Duke University and UCSF. Dr. Adam is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pseudomyxoma Peritonei, Gastrointestinal Stromal Tumor, Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy.

Lejla Delic is an Oncologist and an Obstetrics and Gynecologist in San Francisco, California. Dr. Delic is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Endometrial Cancer, Bladder Reconstruction, and Hysterectomy.

Dr. Edwin Alexander Alvarez is a gynecologic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. He focuses on the surgical and medical treatment of ovarian cancer, cervical cancer, endometrial cancer and other cancers of the female reproductive system. He performs traditional, complicated and minimally invasive gynecologic surgeries. UCSF recruited Alvarez to serve as director of clinical trials for the Division of Gynecologic Oncology. He is involved with NRG Oncology, a cooperative research group for cancer clinical trials sponsored by the National Cancer Institute. Before coming to UCSF, he directed chemotherapy services for gynecologic cancers at the University of California, Davis. In addition to caring for patients, Alvarez has a strong commitment to teaching medical students, residents and fellows. Dr. Alvarez is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Hernia Surgery.

Dr. Eric Nakakura is a cancer surgeon who specializes in tumors of the liver, pancreas, bile ducts and gastrointestinal tract. He also treats soft tissue sarcomas, including tumors of the retroperitoneum (a space in the abdominal cavity), trunk and extremities. At the UCSF Helen Diller Family Comprehensive Cancer Center, he helps manage complex gastrointestinal tract cancers, soft tissue sarcomas and gastrointestinal neuroendocrine tumors, including carcinoid and islet cell tumors. In his research, Nakakura studies endocrine differentiation in gastrointestinal tumors. Nakakura earned his medical degree at Stanford University School of Medicine. He earned a doctorate in cellular and molecular medicine at Johns Hopkins University. He completed a residency in general surgery at Johns Hopkins Medicine and received advanced training in surgery at the John Radcliffe Hospital in Oxford, England. At Johns Hopkins, he completed a fellowship in surgical oncology with an emphasis on pancreatic, biliary and gastrointestinal surgery. Dr. Nakakura is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Retroperitoneal Liposarcoma, Pancreatectomy, and Pancreaticoduodenectomy.

Dr. Katherine Fuh is a gynecologic oncologist who specializes in diagnosing and managing cancers of the female reproductive system, including advanced ovarian and uterine cancers. Her expertise includes chemotherapy, targeted therapy and immunotherapy. Fuh earned her medical degree at Georgetown University School of Medicine. She completed a residency in obstetrics and gynecology at Stanford University, where she also earned a doctorate in cancer biology. She completed a fellowship in gynecologic oncology through a joint program of UCSF and Stanford Medicine. As a physician-scientist, Fuh studies how to improve outcomes for patients with ovarian or uterine cancer. She is nationally known for her use of molecular biomarkers (measurable biological indicators of disease) to guide and personalize therapy. Her laboratory focuses on identifying biomarkers associated with treatment resistance in patients with ovarian cancer and developing targeted therapies to overcome the resistance. She has been involved in numerous clinical trials (studies that use human volunteers to evaluate promising treatments) and is the principal investigator for one of the first clinical trials of a new drug for patients with treatment-resistant metastatic ovarian cancer. She is also the principal investigator on multiple research projects that received grants from various federal funders and foundations. She has published many scientific papers on gynecologic cancers, and her research has advanced how doctors approach treating these diseases. Prior to joining UCSF, Fuh was a faculty member at Washington University School of Medicine in St. Louis. In addition to directing translational and basic research there, she was an integral member of the division of gynecologic cancer and the cancer center. Dr. Fuh is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Oophorectomy, and Hysterectomy.

Dr. Kenzo Hirose is a surgeon who cares for patients with benign or cancerous conditions affecting the liver, pancreas and bile ducts. He has expertise in using minimally invasive surgical techniques, which are generally safer and cause less post-op pain than traditional surgery. In his research, Hirose is interested in improving patient outcomes after surgery. Hirose earned his medical degree at Harvard Medical School. He completed a residency in general surgery at UCSF and a fellowship in liver, pancreatic and biliary tract surgery at the Cleveland Clinic. Dr. Hirose is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pancreatic Cancer, Chronic Pancreatitis, Hereditary Pancreatitis, Pancreatectomy, and Pancreaticoduodenectomy.

Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus. In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies. Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001. Dr. Ko is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Stomach Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Wesley Kidder is a gastrointestinal oncologist with a special interest in colon and rectal cancers as well as neuroendocrine tumors (cancer cells arising from the endocrine and nervous systems). Kidder studies the role that the gut microbiome – the microorganisms that live in the digestive tract – plays in the development and treatment of colon and rectal cancers. His research includes examining the changes in the microbiome that occur following treatment with oral chemotherapy. After earning a master of public health degree from the University of Southern California, Kidder earned his medical degree at the George Washington University School of Medicine and Health Sciences. He then completed a residency in internal medicine at the University of California, San Diego, where he served as chief resident. He completed a fellowship in hematology and medical oncology at UCSF, where he also served as the chief fellow for his final two years. Kidder belongs to the American Society of Clinical Oncology and American Society of Hematology. Dr. Kidder is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Neuroendocrine Tumor.

Dr. Luai Al Rabadi is a medical oncologist who specializes in caring for patients with cancers of the digestive system. In his research, Al Rabadi focuses on improving cancer outcomes by studying prevention strategies, new therapies, and trends in how patients receive care. His research aims to provide patients with more effective and personalized treatment options. Al Rabadi earned his medical degree from the Royal College of Surgeons in Ireland. He completed a residency in internal medicine at MetroHealth Medical Center, an affiliate of Case Western Reserve University. He completed a fellowship in hematology and medical oncology at Oregon Health & Science University. Outside of work, Al Rabadi enjoys spending time with family, being outdoors, and watching and playing soccer. Dr. Rabadi is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Lynch Syndrome, Colorectal Cancer, Familial Colorectal Cancer, and Acute Monoblastic Leukemia (AmoL).

Lee-may Chen is an Obstetrics and Gynecologist in San Francisco, California. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Desmoplastic Small Round Cell Tumor, Salpingo-Oophorectomy, and Oophorectomy.

Giovanni Begossi is a General Surgeon in Oakland, California. Dr. Begossi is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Hyperparathyroidism, Colorectal Cancer, Gallbladder Cancer, Parathyroidectomy, and Thyroidectomy. Dr. Begossi is currently accepting new patients.

Chloe Atreya is a Hematologist in San Francisco, California. Dr. Atreya is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Anal Cancer, Lynch Syndrome, and Hepatectomy.

Alan Venook is a Hematologist in San Francisco, California. Dr. Venook is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Liver Cancer, Bone Marrow Transplant, and Pancreatectomy.

Ari Baron is an Oncologist in San Francisco, California. Dr. Baron is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Liver Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration.

Michael Bookman is a Hematologist Oncology specialist and an Oncologist in San Francisco, California. Dr. Bookman is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Ovarian Cancer, Testicular Yolk Sac Tumor, Vaginal Cancer, and Ovarian Carcinosarcoma. Dr. Bookman is currently accepting new patients.

Amy Lin is a Hematologist and an Oncologist in San Francisco, California. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Lin is currently accepting new patients.

Carlos Corvera is a Surgical Oncologist in San Francisco, California. Dr. Corvera is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pancreatic Cancer, Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Hepatectomy.